The simulation training platform is not only a training platform for doctors, but also a powerful specialized social network for discussing clinical cases and sharing experience between doctors. Therefore, setting up your own profile photo and profile cover photo is an integral part of setting up a personal user profile, which is important for further convenient communication with colleagues. First, you need to log in with your login and password.

Log in to your profile by clicking on the avatar in the top drop-down menu.

Profile photo

To add a profile photo, click on the profile portrait image. Then click “Select file” and select the image on your device.

After uploading the image, select the active area of ​​the image you want to see as an avatar – profile photo. And then click “Crop Photo”. If you successfully add a profile photo, you will see a green bar indicating that your new profile photo has been successfully uploaded.

To make sure that your profile photo is displayed correctly, click “View my profile”.

The profile photo is now also displayed in the top bar of the site next to your name.

You can delete a profile photo at any time by clicking on it and by selecting “Delete”. You can also take a picture of yourself with your device’s webcam. Click “Capture” and save the image. You can train several times. Remember to give your device permission to capture images.

Cover image

You can add a profile cover image from the “Edit Profile” page or by viewing a personal profile.

Click “Edit Cover Photo” and “Select file” and select the desired image on your device, preferably at least 1950 px wide and 450 px high. If you successfully upload the cover photo, you will see a green line with a message. You can delete the cover photo at any time and upload more.

To move the cover image, left-click and move the image so that you are satisfied with the active visible area of ​​the cover image. Save changes. Profile photos and profile cover images will appear in your profile and help you connect with colleagues to communicate.

But that’s not all. The “ClinCaseQuest” simulation training platform is an international platform for doctors from all over the world. We must be ready to build international communication with colleagues. Therefore, you can visit the Ukrainian-language and Russian-language platforms and add your profile photos and covers.

Now you are ready for international communication in the “ClinCaseQuest” simulation training platform!

Register on our website right now to have access to more learning materials!

Register

Charlson Comorbidity Index (CCI) Online Calculator

May 10, 2023

Charlson Comorbidity Index predicts 10-year survival in patients with multiple comorbidities.

Loading...

Email (indicate if you want the results to be sent to your email)

Date of assessment

---

Age *

<50 years

50–59 years

60–69 years

70–79 years

≥80 years

Myocardial infarction *

History of definite or probable MI (EKG changes and/or enzyme changes)

No

Yes

Congestive heart failure *

Exertional or paroxysmal nocturnal dyspnea and has responded to digitalis, diuretics, or afterload reducing agents

No

Yes

Peripheral vascular disease *

Intermittent claudication or past bypass for chronic arterial insufficiency, history of gangrene or acute arterial insufficiency, or untreated thoracic or abdominal aneurysm (≥6 cm)

No

Yes

Cerebrovascular accident or Transient ischemic attack *

History of a cerebrovascular accident with minor or no residua and transient ischemic attacks

No

Yes

Dementia *

Chronic cognitive deficit

No

Yes

Chronic obstructive pulmonary disease *

No

Yes

Connective tissue disease *

No

Yes

Peptic ulcer disease *

Any history of treatment for ulcer disease or history of ulcer bleeding

No

Yes

Liver disease *

Severe = cirrhosis and portal hypertension with variceal bleeding history, moderate = cirrhosis and portal hypertension but no variceal bleeding history, mild = chronic hepatitis (or cirrhosis without portal hypertension)

None

Mild

Moderate to severe

Diabetes mellitus *

None or diet-controlled

Uncomplicated

End-organ damage

Hemiplegia *

No

Yes

Moderate to severe chronic kidney disease *

Severe = on dialysis, status post kidney transplant, uremia, moderate = creatinine >3 mg/dL (0.27 mmol/L)

No

Yes

Solid tumor *

None

Localized

Metastatic

Leukemia *

No

Yes

Lymphoma *

No

Yes

AIDS *

No

Yes

---

Charlson Comorbidity Index

10-year survival

Details:

Reset

* Required

VariablePointsAge <50…

Read More

Multiple Myeloma Diagnostic Criteria – Online Calculator

February 5, 2023

Loading...

Email (indicate if you want the results to be sent to your email)

Date of assessment

---

≥1 of the following (A or B)

*

A. Clonal bone marrow plasma cells ≥10%

B. Biopsy-proven bony or extramedullary plasmacytoma

≥1 myeloma defining event (C1 or C2)

• C1. End organ damage attributable to underlying plasma cell disorder (≥1 of the following): *

o Hypercalcemia (Serum calcium >1 mg/dL (>0.25 mmol/L) higher than upper limit of normal or >11 mg/dL (>2.75 mmol/L))

o Renal insufficiency (Creatinine clearance<40 mL per min or serum creatinine >2 mg/dL (177 μmol/L))

o Anemia (Hemoglobin >2 g/dL (20 g/L) below lower limit of normal

o Bone lesions (≥1 osteolytic lesion on skeletal x-ray

• C2. ≥1 of the following biomarkers of malignancy: *

o Clonal bone marrow plasma cells ≥60%

o Involved:uninvolved sFLC ratio ≥100

o >1 focal lesion on MRI

---

Result

Diagnostic result Negative. Not positive for multiple myeloma by IMWG criteria

Diagnostic result Positive for multiple myeloma by IMWG criteria

Details:

Reset

* Required

For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the…

Read More

Revised Multiple Myeloma International Staging System (R-ISS) Online Calculator

January 17, 2023

Revised Multiple Myeloma International Staging System (R-ISS) – prognostication tool for myeloma patients based on…

Read More

Multiple Myeloma International Staging System (ISS) Online Calculator

January 16, 2023

Multiple Myeloma International Staging System (ISS) prognosticates the severity of multiple myeloma based on routinely…

Read More

SAVED VTE Score

January 11, 2023

SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More

IMPEDE VTE Score

January 11, 2023

IMPEDE score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More